MATTHEW POVLICH: Open Payments
NPI 1194305193 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 25 payments from 8 companies in 2025. Trend: 2023 $40 · 2024 $251 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Alnylam Pharmaceuticals Inc. | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
| Novo Nordisk Inc | 3 | $70 |
| HEARTFLOW, INC. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Liquidia Technologies, Inc. | 1 | $26 |
Products named: ONPATTRO, Wegovy, ELIQUIS, FFRct, LEQVIO, Kerendia, YUTREPIA, CAMZYOS.
Industry payments across WI — which companies pay providers there.
